Relaxation of heart muscle by catecholamines and by dibutyryl cyclic adenosine 3',5'-monophosphate. Similarity of beta-adrenoceptors mediating contractile and relaxant effects of catecholamines in kitten pipillary muscle
- PMID: 14305
- DOI: 10.1007/BF00498687
Relaxation of heart muscle by catecholamines and by dibutyryl cyclic adenosine 3',5'-monophosphate. Similarity of beta-adrenoceptors mediating contractile and relaxant effects of catecholamines in kitten pipillary muscle
Abstract
1. In isometrically contracting kitten papillary muscles, dibutyryl cyclic AMP (DBcAMP) enhanced peak tension, increased rates of contraction and relaxation, decreased tension of a phasic but not of a small tonic component of KCl-contractures, and caused aftercontractions. These effects resemble closely those of catecholamines. 2. The effects of DBcAMP on kitten papillary muscle were not influenced by (-)-bupranolol, a beta-adrenoceptor antagonist. 3. DBcAMP decreased KCl-contractures in strips of frog ventricle. 4. Phasic KCl-contractures in kitten papillary muscles were decreased by (-)- and (+)-isoprenaline. For similar effects, 100-fold higher concentrations of (+)-isoprenaline than of (-)-isoprenaline were required. 5. Increases in maximum rates of contraction and relaxation, increases in peak tension of isometric contractions and reduction of phasic KCl-contractures by catecholamines were antagonized competitively to a similar extent by (-)-bupranolol. Mean apparent equilibrium constants for the beta-adrenoceptor-(-)-bupranolol complex of 0.46-0.70 nM were estimated. These constants were quite similar irrespective of whether (-)-isoprenaline, (+)-isoprenaline or (-)-noradrenaline were used as agonists. 6. Increases in contractile strength, maximum rates of contraction and of relaxation of isometric contractions and decreases in KCl-contractures by (-)-isoprenaline were surmountably blocked by (+)-bupranolol. Mean apparent equilibrium constants for the receptor-(+)-bupranolol complex were 40-50 nM. 7. The equilibrium constants of (-)- and (+)-bupranolol for the receptors mediating positive inotropic and relaxant effects of catecholamines were not significantly different from constants for bupranolol-receptor complexes in cell-free membrane particles of kitten heart ventricle. It is suggested that the same beta-adrenoceptor triggers positive inotropic, relaxant and adenylyl cyclase-activating effects of catecholamines in kitten papillary muscle. 8. The partial agonist (-)-dichloroisoprenaline (DCI) (1 muM) reduced by 79% the phasic KCl-contractures of the kitten papillary muscles. DCI stimulates adenylyl cyclase activity of ventricle membranes to less than 1/4 of maximum stimulation by (-)-isoprenaline. If cyclic AMP produced by DCI is involved in the decrease of phasic KCl-contracture, small increase in cyclic AMP should be sufficient to induce this effect.
Similar articles
-
On minimum cyclic AMP formation rates associated with positive inotropic effects mediated through beta 1-adrenoceptors in kitten myocardium. Beta 1-specific and non-adrenergic stimulant effects of denopamine.Naunyn Schmiedebergs Arch Pharmacol. 1989 Jan-Feb;339(1-2):113-28. doi: 10.1007/BF00165133. Naunyn Schmiedebergs Arch Pharmacol. 1989. PMID: 2566921
-
Activation of myocardial beta-adrenoceptors by the nitrogen-free low affinity ligand 3',4'-dihydroxy-alpha-methylpropiophenone (U-0521).Naunyn Schmiedebergs Arch Pharmacol. 1977 Feb;296(3):217-28. doi: 10.1007/BF00498688. Naunyn Schmiedebergs Arch Pharmacol. 1977. PMID: 14306
-
Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat.Br J Pharmacol. 1996 Aug;118(8):2085-98. doi: 10.1111/j.1476-5381.1996.tb15648.x. Br J Pharmacol. 1996. PMID: 8864547 Free PMC article.
-
Proposal for the interaction of non-conventional partial agonists and catecholamines with the 'putative beta 4-adrenoceptor' in mammalian heart.Clin Exp Pharmacol Physiol. 1997 Sep-Oct;24(9-10):647-56. doi: 10.1111/j.1440-1681.1997.tb02107.x. Clin Exp Pharmacol Physiol. 1997. PMID: 9315364 Review.
-
Effects of catecholamines on plasma potassium: the role of alpha- and beta-adrenoceptors.Fundam Clin Pharmacol. 1993;7(3-4):143-53. doi: 10.1111/j.1472-8206.1993.tb00228.x. Fundam Clin Pharmacol. 1993. PMID: 8388847 Review.
Cited by
-
On minimum cyclic AMP formation rates associated with positive inotropic effects mediated through beta 1-adrenoceptors in kitten myocardium. Beta 1-specific and non-adrenergic stimulant effects of denopamine.Naunyn Schmiedebergs Arch Pharmacol. 1989 Jan-Feb;339(1-2):113-28. doi: 10.1007/BF00165133. Naunyn Schmiedebergs Arch Pharmacol. 1989. PMID: 2566921
-
Evidence that (+)-bupranolol interacts directly with myocardial beta-adrenoceptors. Control of optical purity with differential thermal analysis.Naunyn Schmiedebergs Arch Pharmacol. 1980 Aug;313(1):1-8. doi: 10.1007/BF00505796. Naunyn Schmiedebergs Arch Pharmacol. 1980. PMID: 6259541
-
In kitten ventricular myocardium, the inotropic potency of an agonist is determined by both its intrinsic activity for the adenylyl cyclase and its affinity for the beta-adrenoceptors.Naunyn Schmiedebergs Arch Pharmacol. 1981 Aug;317(1):13-8. doi: 10.1007/BF00506250. Naunyn Schmiedebergs Arch Pharmacol. 1981. PMID: 6116196 No abstract available.
-
A novel analysis of concentration-dependence of partial agonism Ring-demethylation of bupranolol results in a high affinity partial agonist (K 105) for myocardial and tracheal beta-adrenoceptors.Naunyn Schmiedebergs Arch Pharmacol. 1982 Aug;320(2):130-44. doi: 10.1007/BF00506313. Naunyn Schmiedebergs Arch Pharmacol. 1982. PMID: 6289139
-
3H-(-)-Bupranolol, a new beta-adrenoceptor radioligand: characterization of its binding to kitten heart beta-adrenoceptors.Naunyn Schmiedebergs Arch Pharmacol. 1981 Aug;317(1):19-25. doi: 10.1007/BF00506251. Naunyn Schmiedebergs Arch Pharmacol. 1981. PMID: 6269002 No abstract available.